Intellectual property rights must be backed by a strong enforcement mechanism that will effectively curb counterfeiting and piracy, an official of the World Intellectual Property Organisation said in New Delhi on Thursday.
Fuelled by growing markets and a liberalised economy, the Indian biotech industry is set to witness an exponential growth with an estimated turnover of $4,500 million by 2010.
A model train, on show at the Sixth Shanghai International Industry Fair, attracted many professional visitors.
The Biden administration had been under pressure to send the excess COVID-19 vaccines with the US to nations like India, which are facing severe vaccine shortages.
While the innovators see data protection as an essential step to spur R&D, generics deem it as ploy to ensure monopoly by yet another name.
The warring promoters of FMCG major Britannia - the Wadias and the French dairy giant Danone - are looking at sorting out intellectual property rights issues
In January last year, the US signed the first phase of the trade deal with China, which former President Donald Trump described as historic, concluding more than a year of tough negotiations including several months of suspension of talks between the two largest economies of the world.
The country has the opportunity of creating new business models, products and services for the poor not just at home, but for countries in Africa and Latin America.
Concerned over attempts to monopolise its traditional knowledge, India on Tuesday asked the United States to tighten its Intellectual Property Rights regime and put in place proper disclosure norms for companies filing for patents.
The US-India CEO Forum has come out with a far-reaching reform agenda, including opening up of retail sector and raising FDI caps in insurance, banking, print media and broadcasting.
'The vaccine policy should be such that all people should get the vaccine free.'
India, with its strong research and development base in life sciences, IT and pharma industries, is on the threshold of a revolution in biotechnology, scientists at the BioAsia 2004 Summit said in Hyderabad on Thursday.
In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.
The World Intellectual Property Organistion (Wipo)'s Worldwide Academy on Saturday urged the Indian industries to invest heavily in human resource development in the field of intellectual property.
Come year 2005, a catastrophe is set to hit developing nations including India, experts warn, as the TRIPs agreement tightens its noose on the pharmaceutical sector and the governments retire to the role of an onlooker at the rising prices of drugs.
The Bill says that the central government, in consultation with the Data Protection Authority, can direct any data fiduciary or data processor to provide non-personal data to enable better targeting of delivery of services. The government can also ask data processors to provide data for formulation of evidence-based policies for its own use.
Cancun appears headed for a fiasco like Seattle with Tokyo World Trade Organisation mini-ministerial hitting roadblocks.
Expressing concern over the growing menace of counterfeiting, various sectors of the industry demanded high priority to issues of Intellectual Property Rights and speedy trials and better conviction rate for the related offences.\n\n\n\n
The two firms have signed an advanced development deal that will provide BT with a novel automated resource management system.
India could lose over $130 billion annually, if western countries were allowed to exploit and dilute ayurveda, one of the trusted age-old Indian medicine system, experts say.
Let's look at the major provisions that will have lasting effect on the industry, both domestic and exports.
India on Wednesday maintained that its laws were compliant with the trade related intellectual property rights, dismissing the United States concern over New Delhi's "reluctance" to adopt TRIPS compliant patent law.
In a significant development, Asian economic giants India and China have decided to coordinate positions on contentious trade and investment issues like agriculture, Trade Related Intellectual Property Rights and public health and investment.
Federation of Indian Chambers of Commerce and Industry on Wednesday asked the US to restore the Generalised System of Preferences for Indian exports of chemicals and allied products.\n\n\n\n
Chief Justice of India N V Ramana on Wednesday termed as "very unfortunate" certain "speculations and reports" in the media about the collegium meeting regarding the appointment of judges in the Supreme Court.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances